ENTITY
Lepu Biopharma

Lepu Biopharma (2157 HK)

64
Analysis
Health CareChina
Lepu Biopharma Co Ltd operates as a biopharmaceutical company focusing on oncology therapeutics. The Company serves the unmet medical needs of cancer patients. Lepu Biopharma combines in-house research, development, and strategic collaborations to strengthen in-house manufacturing, and commercialize pipeline products through sales and marketing.
more
25 Feb 2022 10:16

Jinmao Property Services IPO - Premium Asking Valuation and Cornerstones Took up 80% of Deal

Jinmao Property Services (JM HK) is looking to raise around US$105m in its Hong Kong IPO. In this note, we will look at deal dynamics, assumptions,...

Logo
474 Views
Share
bearishYunkang Group
24 Feb 2022 14:14

Yunkang Group Pre-IPO - Would Need to Prove Itself Post-COVID

Yunkang Group (YK HK) is looking to raise about US$200m in its upcoming Hong Kong IPO. While it has managed to grow its on-site centers, it has to...

Logo
375 Views
Share
22 Feb 2022 11:37

Lepu Biopharma (乐普生物科技) IPO Trading: High Share Concentration

We provide an update on latest information on Lepu Biopharma prior to debut tomorrow. Subscription is poor and the shares are highly concentrated.

Logo
239 Views
Share
20 Feb 2022 08:55

ECM Weekly (20th Feb 2022) - LIC, SBI Sumishin, Huitongda, Delhivery, Vedant, Persol, Emcure, Linom

Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.

Logo
421 Views
Share
bullishLinmon Media
15 Feb 2022 11:13

Linmon Media (柠萌影业) Pre-IPO - Consistently Putting up a Good Show

Linmon Media (LM HK) is looking to raise about US$300m in its upcoming Hong Kong IPO. In this note, we take a look at LM’s business, financials,...

Logo
472 Views
Share
x